Clinical Trials

With its world-renowned and award-winning academic team and strong affiliation with the Centre for Heart Rhythm Disorders at the University of Adelaide, the Cardiovascular Centre has been at the forefront of developing new and innovative treatment approaches to heart problems. You may have the opportunity to be involved in one of our clinical trials during the course of your treatment. If you are eligible and willing, our team will discuss this with you in more detail.

  • PERSIST-END
  • OCEAN
  • CARDIALEN
  • CAPLA
  • OCEAN
  • SOLVE
  • CAAN-AF
  • EV-ECD
  • INFORM-ICD
  • CAPRI
  • SLEEP-AF
  • HIGH-IMPACT
  • LIVE
  • STEP ICD

Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System

ANZCTR Trial ID: NCT01965899

Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation

ANZCTR Trial ID: NCT01522898

ClinicalTrials.gov Id: NCT02030418

LEADLESS is the world's smallest pacemaker. The LEADLESS trial is a prospective, non-randomized, single-arm, international multicenter, clinical safety and effectiveness investigation.

Please contact Johnathon Foote for more information.

Clinical Trial Co-ordinator

Page 1 of 2
  • Professor Sanders says...

     
    Atrial fibrillation is a consequence of several reversible risk factors - high blood pressure, diabetes, obesity, sleep apnoea, and excessive alcohol. Your management of atrial fibrillation must include strict control of these risk factors.